Material-to-cell synNotch ligand platforms
Delivery StrategyMaterial-to-cell synNotch ligand platforms are engineered biomaterial and extracellular matrix systems that present synNotch ligands to mammalian cells. In the reported 2023 implementation, ligands were covalently incorporated into gelatin hydrogels or into cell-generated fibronectin-containing extracellular matrix to activate synthetic Notch receptors and induce programmed transcriptional outputs.